Is a 'predictable' and 'manageable' phase of COVID finally upon us?

While the COVID-19 pandemic (unfortunately) has yet to come to an end, America may be entering a new phase of the crisis, Axios argues, "one in which the country's overall experience with this virus will be less like having a heart attack, and more like managing a lifelong chronic condition."
In some ways, the transition to "endemic" COVID – meaning the virus will become a "predictable, manageable" part of our lives — is already here, Axios says, positing that though the disease is here to stay, the "worst of the pandemic is likely behind us."
The U.S. is, at the moment, averaging about 74,000 new infections daily, a "4 percent increase of the past two weeks," per Axios. And when analyzing individual states, only 4 would qualify as having a low rate of transmission according to CDC guidelines.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Despite that, former FDA Commissioner Scott Gottlieb said recently that "we're close to the end of the pandemic phase of the virus," though former White House COVID adviser Andy Slavitt disagreed and called for an end to the speculation.
But here's the rub — the end of COVID's "pandemic phase" won't mean the end of COVID infections. There will still be breakthrough cases (though less severe) and winter outbreaks (though hopefully not as big or as deadly as before).
And the framework for this state of play, Axios argues, has already arrived. So, as long as "no new variant emerges," (which is of course possible, but not yet an immediate threat), "we have a pretty good idea of where we're headed, and that overall landscape isn't likely to change too dramatically." Read more at Axios.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
FIRE is catching as people want to leave the traditional workforce
In the spotlight Many are taking steps to retire early
-
How might Bari Weiss change CBS News?
Talking Points Is the network trying to ‘appease’ the president?
-
‘A legacy news brand brings a visibility of its own’
Instant Opinion Opinion, comment and editorials of the day
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the rise
The Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts